Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA1869 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | RANTES | 2888.0 | 73 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | RANTES | 215.0 | 65 | |
N2759 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | RANTES | 4432.5 | 60 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | RANTES | 109.0 | 62 | |
RA1931 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | RANTES | 2217.0 | 81 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 3 | RANTES | 97.0 | 63 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | RANTES | 7846.5 | 78 | |
RA1869 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | RANTES | 22601.0 | 73 | |
RA1869 | TNF-a | 100 | ng/mL | 3 | RANTES | 25832.5 | 64 | ||||
N2759 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | RANTES | 22874.0 | 71 | |
N2759 | TNF-a | 100 | ng/mL | 3 | RANTES | 24808.0 | 65 | ||||
RA1931 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | RANTES | 13132.0 | 60 | |
RA1931 | TNF-a | 100 | ng/mL | 3 | RANTES | 15113.0 | 57 | ||||
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | RANTES | 24899.5 | 66 | |
N2586 | TNF-a | 100 | ng/mL | 3 | RANTES | 26902.0 | 63 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 3 | RANTES | 38.5 | 64 | ||||
RA1869 | IKK16 | 2.0 | uM | 3 | RANTES | 30.0 | 75 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 3 | RANTES | 32.0 | 79 | ||||
N2759 | IKK16 | 2.0 | uM | 3 | RANTES | 24.0 | 62 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 3 | RANTES | 31.5 | 86 | ||||
RA1931 | IKK16 | 2.0 | uM | 3 | RANTES | 32.0 | 91 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 3 | RANTES | 35.0 | 64 | ||||
N2586 | IKK16 | 2.0 | uM | 3 | RANTES | 109.5 | 62 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 3 | RANTES | 27.0 | 56 | ||||
RA1869 | 3 | RANTES | 34.0 | 78 |